Journal of opioid management · 2024
Monitoring buprenorphine in patients on medication-assisted treatment.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pesce Amadeo, Bollman Katie, Krock Kevin, Cua Agnes, Tran Keith, Thomas Richard
Аннотация
BACKGROUND: Buprenorphine is used for medication-assisted treatment of opioid dependence.
PURPOSE: Monitoring of medication adherence involves testing of urine or oral fluid for the drug or its metabolite.
METHODS: Quantitative results using liquid chromatography tandem mass spectrometer testing defined the excretion pattern of the drug and its metabolites.
RESULTS: Frequency distribution curves of buprenorphine and norbuprenorphine describe the expected drug concentrations of patients on this medication.
CONCLUSION: Urine and oral fluid drug testing can be used to monitor adherence in this population.
PURPOSE: Monitoring of medication adherence involves testing of urine or oral fluid for the drug or its metabolite.
METHODS: Quantitative results using liquid chromatography tandem mass spectrometer testing defined the excretion pattern of the drug and its metabolites.
RESULTS: Frequency distribution curves of buprenorphine and norbuprenorphine describe the expected drug concentrations of patients on this medication.
CONCLUSION: Urine and oral fluid drug testing can be used to monitor adherence in this population.